INCY
Common StockINCYTE CORP
Reported Shares
30.8M
Position Mix
No options reported
Reported Value
$3.7B
Portfolio Weight
17.79%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$21.0B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
INCY
Common StockINCYTE CORP
Reported Shares
30.8M
Position Mix
No options reported
Reported Value
$3.7B
Portfolio Weight
17.79%
ONC
Depositary ReceiptBeOne Medicines Ltd.
Reported Shares
8.8M
Position Mix
No options reported
Reported Value
$3.2B
Portfolio Weight
15.40%
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
10.6M
Position Mix
No options reported
Reported Value
$2.2B
Portfolio Weight
10.40%
KOD
Common StockKodiak Sciences Inc.
Reported Shares
21.9M
Position Mix
No options reported
Reported Value
$2.1B
Portfolio Weight
9.87%
MDGL
Common StockMADRIGAL PHARMACEUTICALS, INC.
Reported Shares
2.1M
Position Mix
No options reported
Reported Value
$1.1B
Portfolio Weight
5.15%
INSM
Common StockINSMED Inc
Reported Shares
8.8M
Position Mix
No options reported
Reported Value
$1.0B
Portfolio Weight
4.78%
KYMR
Common StockKymera Therapeutics, Inc.
Reported Shares
8.7M
Position Mix
No options reported
Reported Value
$967.8M
Portfolio Weight
4.61%
ACAD
Common StockACADIA PHARMACEUTICALS INC
Reported Shares
42.9M
Position Mix
No options reported
Reported Value
$864.7M
Portfolio Weight
4.12%
GRAL
Common StockGRAIL, Inc.
Reported Shares
4M
Position Mix
No options reported
Reported Value
$564.5M
Portfolio Weight
2.69%
SMMT
Common StockSummit Therapeutics Inc.
Reported Shares
32.8M
Position Mix
No options reported
Reported Value
$554.4M
Portfolio Weight
2.64%
RYTM
Common StockRHYTHM PHARMACEUTICALS, INC.
Reported Shares
5.6M
Position Mix
No options reported
Reported Value
$533.6M
Portfolio Weight
2.54%
PRAX
Common StockPraxis Precision Medicines, Inc.
Reported Shares
1.8M
Position Mix
No options reported
Reported Value
$510.6M
Portfolio Weight
2.43%
ABCL
Common StockAbCellera Biologics Inc.
Reported Shares
33M
Position Mix
No options reported
Reported Value
$481.6M
Portfolio Weight
2.29%
ALKS
Common StockAlkermes plc.
Reported Shares
10M
Position Mix
No options reported
Reported Value
$405.7M
Portfolio Weight
1.93%
CELC
Common StockCelcuity Inc.
Reported Shares
4.8M
Position Mix
No options reported
Reported Value
$383.0M
Portfolio Weight
1.82%
KNSA
Common StockKiniksa Pharmaceuticals International, plc
Reported Shares
2.8M
Position Mix
No options reported
Reported Value
$211.5M
Portfolio Weight
1.01%
IDYA
Common StockIDEAYA Biosciences, Inc.
Reported Shares
5M
Position Mix
No options reported
Reported Value
$192.5M
Portfolio Weight
0.92%
EWTX
Common StockEdgewise Therapeutics, Inc.
Reported Shares
3.7M
Position Mix
No options reported
Reported Value
$150.3M
Portfolio Weight
0.72%
REPL
Common StockReplimune Group, Inc.
Reported Shares
11M
Position Mix
No options reported
Reported Value
$146.2M
Portfolio Weight
0.70%
ROIV
Common StockRoivant Sciences Ltd.
Reported Shares
3.7M
Position Mix
No options reported
Reported Value
$133.9M
Portfolio Weight
0.64%